| Literature DB >> 29678389 |
Pavel Uhrin1, Dongdong Wang2, Andrei Mocan3, Birgit Waltenberger4, Johannes M Breuss5, Devesh Tewari6, Judit Mihaly-Bison5, Łukasz Huminiecki7, Rafał R Starzyński7, Nikolay T Tzvetkov8, Jarosław Horbańczuk7, Atanas G Atanasov9.
Abstract
Many natural products have been so far tested regarding their potency to inhibit vascular smooth muscle cell proliferation, a process involved in atherosclerosis, pulmonary hypertension and restenosis. Compounds studied in vitro and in vivo as VSMC proliferation inhibitors include, for example indirubin-3'-monoxime, resveratrol, hyperoside, plumericin, pelargonidin, zerumbone and apamin. Moreover, taxol and rapamycin, the most prominent compounds applied in drug-eluting stents to counteract restenosis, are natural products. Numerous studies show that natural products have proven to yield effective inhibitors of vascular smooth muscle cell proliferation and ongoing research effort might result in the discovery of further clinically relevant compounds.Entities:
Keywords: Atherosclerosis; Drug-discovery; Molecular target; Natural products; Restenosis; Signaling pathway; Vascular smooth muscle cell proliferation
Mesh:
Substances:
Year: 2018 PMID: 29678389 DOI: 10.1016/j.biotechadv.2018.04.002
Source DB: PubMed Journal: Biotechnol Adv ISSN: 0734-9750 Impact factor: 14.227